This webinar is part of a series of BIA Brexit Briefings that provide updates for our UK and International audiences answering 'What does Brexit mean for Biotechnology in the UK and beyond?
To provide additional support to the sector the BIA will be running "Brexit Readiness" webinars in the lead up to 31st October.
These webinars start on 27th September and are then running: 4th October, 11th October, and 29th October.
Following the outcome of the UK’s referendum on membership of the European Union, the BIA has worked closely with members and stakeholders to identify the threats and opportunities for biotech post-Brexit and to represent the sector.
Our BIA Brexit Briefing webinars provide updates on Government policy, progress of working groups, and how these potentially affect companies in life sciences.
Steve Bates is the CEO of the UK Bioindustry Association, the UK’s Trade Association for innovative life science companies with over 550 members. Steve is the visible face of the vibrant UK life sciences industry to government and media. He serves on the UK Government’s Life Sciences Council and the UK Biosecurity Leadership Council. Steve was a founder member of the UK Government’s Vaccine Taskforce in the Covid crisis, sitting on its steering Board alongside Kate Bingham. He is active member and former chair the International Council of Biotech Associations and has been a board member of EuropaBio since 2015.
Previous experience & achievements
Steve has championed, with government, effective industrial incentives like the Biomedical Catalyst, which have crowded in private sector investment into UK SMEs. He is a driving force behind the scale up agenda, spearheading policy agenda to unlock UK pension fund capital into productive UK growth in life sciences. He has forged several links for the sector across the USA, Europe and in China. In his time at the BIA, Steve has developed new member groups focused on cell and gene therapy, genomics and engineered biology. A strong advocate of partnership working, Steve champions sector collaboration with research charities and academia. Proud to lead an organisation with a diverse Board with over 40% female representation, Steve is committed to next generation talent and developing the skills needed for the sector to flourish. Before joining the BIA in 2012, Steve worked for Genzyme and was advisor to the UK Government of Tony Blair working on NHS reform and the Northern Ireland peace process. He was made OBE for services to innovation in 2017 and became a Fellow of the Academy of Medical Science in 2020.
Partner, Brexit and Value Chain Management, KPMG UK
Tim Sarson
Partner, Brexit and Value Chain Management, KPMG UK
In the last decade a particular focus of Tim’s has been on developing an integrated tax, commercial and operational approach to transformation projects. He has a particular focus on geography and location, helping companies to adapt to changes in the global landscape of tax, labour, trading flows and geopolitics
Tim is currently advising a number of clients on the impacts of Brexit, working with a wide range of KPMG specialists in supply chain, regulation, customs, immigration, legal services and political intelligence.
Cost
Free for members and non-members
By registering to this event you accept our Terms & Conditions